Mean Reversion
Very Weak
Trend
Neutral
Event
Neutral
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Strong
Earnings
Very Weak
Earnings
Neutral
Dividends
Very Weak
Capital Efficiency
Very Weak
Balance Sheet
Strong
Website
Esperion Therapeutics, Inc.
Telephone
1.734.887.3903
Address
Suite 150, 3891 Ranchero Drive, Ann Arbor, MI 48108
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.76 - 4.18
Trade Value (12mth)
US$4,707,371.00
1 week
0.32%
1 month
63.02%
YTD
-15.63%
1 year
266.94%
All time high
120.96
EPS 3 yr Growth
-96.90%
EBITDA Margin
15.00%
Operating Cashflow
-$13m
Free Cash Flow Return
-10.30%
ROIC
-17.90%
Interest Coverage
0.70
Quick Ratio
1.20
Shares Outstanding (Fully Diluted)
251m
HALO Sector
Healthcare
Next Company Report Date
23-Feb-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 09 May 26 | |
| 09 May 26 | |
| 02 May 26 | |
| 02 May 26 | |
| 02 May 26 |
Historical data
Forecast data
| USD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | -2.03 | -0.28 | -0.11 | | | | ||
EPS (Fully Diluted) | $ | | | | | -2.03 | -0.28 | -0.11 | | | | ||
Growth | % | | | | | 42.3 | 86.4 | 60.5 | | | | ||
PE | X | | | | | N/A | 240.1 | N/A | | | | ||
EV/EBITDA | X | | | | | N/A | 15.7 | 19 | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
